BASAGLAR Trademark

Trademark Overview

On Tuesday, May 6, 2014, a trademark application was filed for BASAGLAR with the United States Patent and Trademark Office. The USPTO has given the BASAGLAR trademark a serial number of 86273009. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 1, 2017. This trademark is owned by Eli Lilly and Company. The BASAGLAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes
basaglar

General Information

Serial Number86273009
Word MarkBASAGLAR
Filing DateTuesday, May 6, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 1, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 17, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, May 1, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 1, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2016EXTENSION 4 GRANTED
Thursday, June 30, 2016EXTENSION 4 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 30, 2016EXTENSION 3 GRANTED
Tuesday, January 26, 2016EXTENSION 3 FILED
Tuesday, January 26, 2016TEAS EXTENSION RECEIVED
Thursday, September 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2015EXTENSION 2 GRANTED
Monday, August 24, 2015EXTENSION 2 FILED
Wednesday, September 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 24, 2015TEAS EXTENSION RECEIVED
Saturday, February 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 12, 2015EXTENSION 1 GRANTED
Thursday, February 12, 2015EXTENSION 1 FILED
Thursday, February 12, 2015TEAS EXTENSION RECEIVED
Tuesday, September 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 17, 2014ASSIGNED TO EXAMINER
Saturday, May 17, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 9, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

basaglar pharmaceutical preparations diabetes namely treatment